1.Farrington CP. Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine 2004; 22: 2064–2070.
2.Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: A comparative evaluation. American Journal of Epidemiology 1996; 143: 1165–1173.
3.Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995; 51: 228–235.
4.Farrington CP, Whitaker HJ. Semiparametric analysis of case series data (with Discussion). Journal of the Royal Statistical Society Series C 2006; 55: 553–594.
5.Whitaker HJ, et al. Tutorial in biostatistics: the self-controlled case series method. Statistics in Medicine 2006; 25: 1768–1797.
6.Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Statistical Methods in Medical Research 2009; 18: 7–26.
7.Andrews NJ. Statistical assessment of the association between vaccination and rare adverse events post-licensure. Vaccine 2002; 20: S49–S53.
8.Musonda P, Farrington CP, Whitaker HJ. Sample sizes for self-controlled case series studies. Statistics in Medicine 2006; 25: 2618–2631.
9.Ali M, et al. The use of a computerized database to monitor vaccine safety in Viet Nam. Bulletin of the World Health Organization 2005; 83: 604–610.
10.Andrews N, et al. Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the United Kingdom. European Journal of Epidemiology 2001; 17: 701–706.
11.Andrews N, et al. Recall bias, MMR, and autism. Archives of Disease in Childhood 2002; 87: 493–494.
12.Andrews N, et al. Post-licensure safety of the meningococcal group C conjugate vaccine. Human Vaccines 2007; 3: 59–63.
13.Andrews N, et al. Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom. Vaccine; 28: 7215–7220.
14.Burwen DR, et al. Evaluating adverse events after vaccination in the Medicare population. Pharmacoepidemiology and Drug Safety 2007; 16: 753–761.
15.Cameron JC, et al. Oral polio vaccine and intussusception: A data linkage study using records for vaccination and hospitalization. American Journal of Epidemiology 2006; 163: 528–533.
16.Dourado I, et al. Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles-mumps-rubella vaccine – Implications for immunization programs. American Journal of Epidemiology 2000; 151: 524–530.
17.Farrington P, et al. A new method for active surveillance of adverse events from diphtheria-tetanus-pertussis and measles-mumps-rubella vaccines. Lancet 1995; 345: 567–569.
18.Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine 2001; 19: 3632–365.
19.France EK, et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008; 121: e687–e692.
20.Gold M, et al. Use of the Australian Childhood Immunisation Register for vaccine safety data linkage. Vaccine 2010; 28: 4308–4311.
21.Gwini SM, Coupland CAC, Siriwardena AN. The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study. Vaccine 2011; 29: 1145–1149.
22.Hambidge SJ, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. Journal of the American Medical Association 2006; 296: 1990–1997.
23.Hocine MN, et al. Hepatitis B vaccination and first central nervous system demyelinating events: Reanalysis of a case-control study using the self-controlled case series method. Vaccine 2007; 25: 5938–5943.
24.Huang WT, et al. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics 2010; 126: E263–E269.
25.Hughes RA, et al. No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000. Archives of Internal Medicine 2006; 166: 1301–1304.
26.Juurlink DN, et al. Guillain-Barré syndrome after influenza vaccination in adults – a population-based study. Archives of Internal Medicine 2006; 166: 2217–2221.
27.Kramarz P, et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Archives of Family Medicine 2000; 9: 617–623.
28.Kramarz P, et al. Does influenza vaccination prevent asthma exacerbations in children? Journal of Pediatrics 2001; 138: 306–310.
29.Miller E, et al. Bacterial infections, immune overload, and MMR vaccine. Archives of Disease in Childhood 2003; 88: 222–223.
30.Miller E, et al. No evidence of an association between MMR vaccine and gait disturbance. Archives of Disease in Childhood 2005; 90: 292–296.
31.Miller E, et al. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. American Journal of Epidemiology 2007; 165: 704–709.
32.Miller E, et al. Idiopathic thrombocytopenic purpura and MMR vaccine. Archives of Disease in Childhood 2001; 84: 227–229.
33.Mullooly JP, et al. Wheezing lower respiratory disease and vaccination of full-term infants. Pharmacoepidemiology and Drug Safety 2002; 11: 21–30.
34.Murphy TV, et al. Intussusception among infants given an oral rotavirus vaccine. New England Journal of Medicine 2001; 344: 564–572.
35.Mutsch M, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. New England Journal of Medicine 2004; 350: 896–903.
36.Naleway AL, et al. Risk of immune hemolytic anemia in children following immunization. Vaccine 2009; 27: 7394–7397.
37.Payne DC, et al. Concurrent vaccinations and US military hospitalizations. Annals of Epidemiology 2007; 17: 697–703.
38.Sardinas MAG, et al. Lack of association between intussusception and oral polio vaccine in Cuban children. European Journal of Epidemiology 2001; 17: 783–787.
39.Smeeth L, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. New England Journal of Medicine 2004; 351: 2611–2618.
40.Stowe J, et al. Idiopathic thrombocytopenic purpura and the second dose of MMR. Archives of Disease in Childhood 2001; 93: 182–183.
41.Stowe J, et al. Bell's palsy and parenteral inactivated influenza vaccine. Human Vaccines 2006; 2: 110–112.
42.Stowe J, et al. Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenz-alike illness using the United Kingdom General Practice Research Database. American Journal of Epidemiology 2008; 169: 382–388.
43.Stowe J, et al. No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine. Vaccine 2009; 27: 1422–1425.
44.Tata LJ, et al. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003; 58: 835–839.
45.Taylor B, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353: 2026–2029.
46.Taylor B, et al. No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Archives of Disease in Childhood 2007; 92: 887–889.
47.Ward KN, et al. Risk of serious neurologic disease after immunization of young children in Britain and Ireland. Pediatrics 2007; 120: 314–321.
48.Zinman L, et al. Safety of influenza vaccination in patients with myasthenia gravis: A population-based study. Muscle and Nerve 2009; 40: 947–951.
49.van der Maas NAT, et al. Acute cerebellar ataxia in the Netherlands: A study on the association with vaccinations and varicella zoster infection. Vaccine 2009; 27: 1970–1973.
50.France EK, et al. Safety of the trivalent inactivated influenza vaccine among children. Archives of Pediatric and Adolescent Medicine 2004; 158: 1031–1036.
51.Klein NP, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010; 126: e1–e8.
52.Farrington CP, Hocine MN. Within-individual dependence in self-controlled case series models for recurrent events. Journal of the Royal Statistical Society Series C 2010; 59: 457–475.
53.Farrington CP, et al. Self-controlled case series analysis with event-dependent observation periods. Journal of the American Statistical Association 2011; 106: 417–426.
54.Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 2009; 10: 3–16.
55.Kuhnert R, et al. A modified self-controlled case series method to examine association between multidose vaccinations and death. Statistics in Medicine 2011; 30: 666–677.
56.Delaney JA, Suissa S. The case-crossover study design in pharmacoepidemiology. Statistical Methods in Medical Research 2009; 18: 53–65.
57.Suissa S. Immortal time bias in pharmacoepidemiology. American Journal of Epidemiology 2007; 167: 492–499.
58.Musonda P, et al. Self-controlled case series analyses: small-sample performance. Computational Statistics and Data Analysis 2008; 52: 1942–1957.
59.Navidi W. Bidirectional case-crossover designs for exposures with time trends. Biometrics 1998; 54: 596–605.
60.Lumley T, Levy D. Bias in the case-crossover design: implications for studies of air pollution. Environmetrics 2000; 11: 689–704.
61.Vines SK, Farrington CP. Within-subject exposure dependency in case-crossover studies. Statistics in Medicine 2001; 20: 3039–3049.
62.Whitaker HJ, Hocine MN, Farrington CP. On case-crossover methods for environmental time series data. Environmentrics 2007; 18: 157–171.
63.Becker NG, Li Z, Kelman CW. The effect of transient exposures on the risk of an acute illness with low hazard rate. Biostatistics 2004; 5: 239–248.
64.Glanz JM, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. Journal of Clinical Epidemiology 2006; 59: 808–818.
65.Musonda P, et al. Monitoring vaccine safety using case series cumulative sum charts. Vaccine 2008; 26: 5358–5367.
66.Hocine MN, et al. Sequential case series analysis for pharmacovigilance. Journal of the Royal Statistical Society. Series A 2009; 172: 213–236.
67.Hocine M, et al. Testing independence between two Poisson-generated multinomial variables in case-series and cohort studies. Statistics in Medicine 2005; 24: 4035–4044.